Cunningham, C K <br/><br/>
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Mar 2001 
 - 801-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1058-4838 
<br/><br/><label>Standard No.: </label>10.1086/319215  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--administration & dosage<br/>Adjuvants, Immunologic--administration & dosage<br/>Female<br/>HIV Envelope Protein gp120--genetics<br/>HIV Infections--prevention & control<br/>Humans<br/>Infant, Newborn<br/>Infectious Disease Transmission, Vertical--prevention & control<br/>Polysorbates--administration & dosage<br/>Pregnancy<br/>Pregnancy Complications, Infectious<br/>Squalene--administration & dosage<br/>Vaccination<br/>Vaccines, Synthetic--administration & dosage